Pfizer and BioNTech have their own offerings for hundreds of millions of shots. The first two Covid-19 vaccines at the door have now delivered positive news in the quest to end the pandemic. Encouraging late-stage test results from Pfizer Inc. and Moderna Inc. set a high bar for rivals such …
Read More »
Moderna Inc said Monday that its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from an advanced-stage clinical trial, becoming the second American company in a week to report results that far exceed expectations. Along with the Pfizer Inc vaccine, which has also been shown to …
Read More »
Pfizer Inc and BioNTech SE have proposed to authorities to expand their Phase 3 COVID-19 vaccine trial to approximately 44,000 participants while increasing the diversity of the trial population. The initial target figure for the covid vaccine trial that the two companies are jointly developing was up to 30,000 participants, …
Read More »
AstraZeneca building in Luton, Great Britain. Tim Ireland | Xinhua News Agency | fake images Phase three trials for AstraZeneca’s coronavirus vaccine have resumed in the UK after they were halted earlier this week over safety concerns, the company announced on Saturday. AstraZeneca said it received confirmation from the UK …
Read More »
A draft of the joint statement, which is still being finalized by companies such as Pfizer Inc., Johnson & Johnson and Moderna Inc. and reviewed by The Wall Street Journal, commits to making the safety and well-being of vaccinated people a priority. of the companies. Vaccine manufacturers would also commit …
Read More »
As the world waits for a vaccine against the deadly coronavirus disease (Covid-19), several major drug developers have decided to make a pledge not to seek government approval until their vaccine candidates are proven safe. The move is seen as a bulwark against mounting political pressure to introduce a vaccine …
Read More »